Evidence map›Paper›PMID 22364820›Full record

ArticleThe Journal of pediatrics2012

Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis.

Deanna M Green, J Michael Collaco, Kathryn E McDougal, Kathleen M Naughton, Scott M Blackman, Garry R Cutting

Open access · greenAbstract readTwin Study
In one paragraph

Article in The Journal of pediatrics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Annals of the American Thoracic Society · 2025
    Article
  4. Article
  5. Observational
  6. Nasal Epithelium Transcriptomics Predict Clinical Response to Elexacaftor/Tezacaftor/Ivacaftor.American journal of respiratory cell and molecular biology · 2024
    Article
  7. Genome-wide association study of susceptibility toThe European respiratory journal · 2024
    Article
  8. Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes.International journal of molecular sciences · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Cystic fibrosis: a clinical view.Cellular and molecular life sciences : CMLS · 2017
    Review
  13. Article
  14. Article
  15. Cystic fibrosis.Nature reviews. Disease primers · 2015
    Review
  16. Article
  17. Review
  18. Article
  19. The influence of genetics on cystic fibrosis phenotypes.Cold Spring Harbor perspectives in medicine · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Deanna M GreenDivision of Pediatric Pulmonary and Sleep Medicine, Duke University Medical Center, Durham, NC, USA.
J Michael Collaco
Kathryn E McDougal
Kathleen M Naughton
Scott M Blackman
Garry R Cutting
Johns Hopkins University · USJohns Hopkins Medicine · USDuke Medical Center · US

Funding

Genetic Modifiers of Cystic Fibrosis: Sibling StudyR01HL068927 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CUTTING, GARRY R · 2001 to 2011
$8.9M
Multidisciplinary Training Program in Pediatric PulmonaryT32HL072748 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Joseph Michael Collaco · 2003 to 2026
$6.1M
Modifier genes in CF-related diabetes and meconium ileusF32DK076446 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI BLACKMAN, SCOTT M · 2006 to 2007
$117k
NHLBI NIH HHS HL068927NHLBI NIH HHS R01 HL068927NHLBI NIH HHS T32 HL072748NIDDK NIH HHS DK076446NIDDK NIH HHS F32 DK076446
6 · The paper itself

Abstract

objectiveTo quantify the relative contribution of factors other than cystic fibrosis transmembrane conductance regulator genotype and environment on the acquisition of Pseudomonas aeruginosa (Pa) by patients with cystic fibrosis. STUDY

designLung infection with Pa and mucoid Pa was assessed using a co-twin study design of 44 monozygous (MZ) and 17 dizygous (DZ) twin pairs. Two definitions were used to establish infection: first positive culture and persistent positive culture. Genetic contribution to infection (ie, heritability) was estimated based on concordance analysis, logistic regression, and age at onset of infection through comparison of intraclass correlation coefficients.

resultsConcordance for persistent Pa infection was higher in MZ (0.83; 25 of 30 pairs) than DZ twins (0.45; 5 of 11 pairs), generating a heritability of 0.76. Logistic regression adjusted for age corroborated genetic control of persistent Pa infection. The correlation for age at persistent Pa infection was higher in MZ twins (0.589; 95% CI, 0.222-0.704) than in DZ twins (0.162; 95% CI, -0.352 to 0.607), generating a heritability of 0.85.

conclusionGenetic modifiers play a significant role in the establishment and timing of persistent Pa infection in individuals with cystic fibrosis.

Indexed as

Pseudomonas aeruginosaAdolescentChildChild, PreschoolCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDiseases in TwinsEpistasis, GeneticFemaleGenes, ModifierHumansMalePseudomonas InfectionsRespiratory Tract InfectionsTwins, DizygoticTwins, MonozygoticCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID22364820
PMCPMC3682831
OpenAlexW2018617522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.